ARUN DANIEL; ATANU KUNDU; BALAMURUGAN; BHABANI BHUYAN; CHAITANYA CHALLA. Combination dual therapy of Empagliflozin and Linagliptin for the management of Type 2 Diabetes. Medico Research Chronicles, v. 7, n. 1, p. 41-44, 29 Feb. 2020.